Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Califf

Showing results (131-140 of 770) with videos related to

Pageof 77
Sort By:
Annals of Neurology|December 21, 2016
Regarding "Eteplirsen for the treatment of Duchenne muscular dystrophy"Ellis F Unger, Robert M Califf
The New England Journal of Medicine|December 6, 2013
Randomized clinical trials--removing obstaclesChristina Reith, Martin Landray, Robert M Califf
JAMA Internal Medicine|October 24, 2022
Benefits of Streamlined Point-of-Care Trial Designs: Lessons Learned From the UK RECOVERY StudyRobert M Califf, Patrizia Cavazzoni, Janet Woodcock
JACC. Basic to Translational Science|September 1, 2018
Resourcing Drug Development Commensurate With its Public Health Importance: The Road AheadMona Fiuzat, Norman Stockbridge, Robert M Califf
The New England Journal of Medicine|February 5, 2016
A Proactive Response to Prescription Opioid AbuseRobert M Califf, Janet Woodcock, Stephen Ostroff
JAMA|February 20, 2025
Regulation of Artificial Intelligence in Health Care and Biomedicine-ReplyHaider Warraich, Troy Tazbaz, Robert M Califf
JAMA|November 8, 2016
Knowing When and How to Use Medical Products: A Shared Responsibility for the FDA and CMSRobert M Califf, Rachel E Sherman, Andrew Slavitt
JAMA Cardiology|September 2, 2019
Consequences of Slow Progress Toward Pragmatism in Randomized Clinical Trials: It Is Time to Get PracticalFatima Rodriguez, Robert M Califf, Robert A Harrington
JAMA Internal Medicine|April 24, 2013
Assessing research results in the medical literature: trust but verifyRobert M Califf, Jonathan McCall, Robert A Harrington
Lancet (London, England)|June 10, 2014
Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetesRury R Holman, Harald Sourij, Robert M Califf
Pageof 77

Showing results (131-140 of 770) with videos related to

Sort By:
Pageof 77
Annals of Neurology|December 21, 2016
Regarding "Eteplirsen for the treatment of Duchenne muscular dystrophy"Ellis F Unger, Robert M Califf
The New England Journal of Medicine|December 6, 2013
Randomized clinical trials--removing obstaclesChristina Reith, Martin Landray, Robert M Califf
JAMA Internal Medicine|October 24, 2022
Benefits of Streamlined Point-of-Care Trial Designs: Lessons Learned From the UK RECOVERY StudyRobert M Califf, Patrizia Cavazzoni, Janet Woodcock
JACC. Basic to Translational Science|September 1, 2018
Resourcing Drug Development Commensurate With its Public Health Importance: The Road AheadMona Fiuzat, Norman Stockbridge, Robert M Califf
The New England Journal of Medicine|February 5, 2016
A Proactive Response to Prescription Opioid AbuseRobert M Califf, Janet Woodcock, Stephen Ostroff
JAMA|February 20, 2025
Regulation of Artificial Intelligence in Health Care and Biomedicine-ReplyHaider Warraich, Troy Tazbaz, Robert M Califf
JAMA|November 8, 2016
Knowing When and How to Use Medical Products: A Shared Responsibility for the FDA and CMSRobert M Califf, Rachel E Sherman, Andrew Slavitt
JAMA Cardiology|September 2, 2019
Consequences of Slow Progress Toward Pragmatism in Randomized Clinical Trials: It Is Time to Get PracticalFatima Rodriguez, Robert M Califf, Robert A Harrington
JAMA Internal Medicine|April 24, 2013
Assessing research results in the medical literature: trust but verifyRobert M Califf, Jonathan McCall, Robert A Harrington
Lancet (London, England)|June 10, 2014
Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetesRury R Holman, Harald Sourij, Robert M Califf
Pageof 77